The impact of initial treatment of advanced stage indolent lymphoma on the risk of transformation.

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 4 de junio del 2006

Translation for this article does not exist